T. Rowe Price Is Buying a Bond-ETF Business Bigger Than the One It Built
T. Rowe Price (TROW) to acquire F/m Investments ($19B AUM, 20 bond ETFs). No price disclosed; no 8-K filed. Gives TROW fixed-income ETF scale. Close early 2027.
Marvell Issues Google Warrant to Buy Up to $12.2B in Shares in Custom AI Chip Deal
Marvell issued Google a warrant (58.97M shares at $206.58/sh, ~$12.2B exercise, ~6.3% post-dilution) vesting on chip purchases through FY2033. MRVL +8%, AVGO -5%.
Amazon Pushes Drones Into 500 Cities as Its Full-Year Target Equals 80 Minutes of Ground Volume
Amazon's drone unit is aiming to fly about a million packages this year. That is roughly 80 minutes of work for the ground delivery network Amazon already runs
Salesforce, Microsoft Weigh Darwinbox Stakes at More Than 30 Times Revenue
The valuation reported for Darwinbox this week works out to more than 30 times the Hyderabad-based HR software maker's last disclosed annual revenue. When Sales
Union Pacific (UNP) Fuel Surcharge Exceeds Diesel by $91M
Union Pacific (NYSE: UNP) collected about $91.1 million more in fuel surcharges than it spent on diesel last quarter. Across the first half of the year, it was the only large U.S. railroad to show a net surplus on that same measure, according to Surface Transportation Board filings.
Justice Kagan Pauses Apple App Store Fee Proceedings — Contempt Case Heads to October Supreme Court Term
Justice Kagan paused App Store link-out fee proceedings for 24 hours on Aug. 12. Apple's contempt fight heads to the Supreme Court's October 2026 term.
Chipotle's 'Guac Signal' Outpaced the FDA on Jalapeño Recall — CMG Shares Down 15% From Post-Q2 High
Chipotle's 'Guac Signal' traced tainted jalapeños before the company-level recall; CMG is down 15% from post-Q2 highs as 345 CDC-confirmed illnesses span 27 states.
Moderna's mFlusiva Wins FDA Approval as First-Ever mRNA Flu Vaccine After Six-Month Regulatory Saga
FDA cleared Moderna's mFlusiva Aug. 5 — first mRNA flu vaccine. 26.6% rVE vs standard shots; ACIP frozen and 2026 contracting missed, so revenue likely delayed to 2027.
J&J Ottava FDA Authorization Gives da Vinci Its Second U.S. Rival — Can ISRG's Moat Hold?
J&J Ottava received FDA de novo authorization July 22, 2026, da Vinci's second U.S. rival after Medtronic Hugo. ISRG Q2 +18.4% revenue, 11,710 systems, stock -35% YTD.
Moderna mFLUSIVA FDA Approved: First mRNA Flu Vaccine Clears U.S. Regulators for Adults 50+
FDA approves mFLUSIVA — first U.S. mRNA flu vaccine. Full approval adults 50-64; accelerated 65+. MRNA +4.3% after-hours. ACIP block limits private-insurer coverage for 50-64.
Apple Seeks Injunction to Block OpenAI From Using Alleged Trade Secrets as Silicon Valley AI Talent War Turns Legal
Apple seeks a court injunction to block OpenAI from using trade secrets stolen by three ex-Apple engineers now at OpenAI. OpenAI fires back publicly.
WBD's Implied Break Price Rises $7 as Buyers Circle Warner
Wall Street has stopped treating a collapsed Paramount–Warner deal as a catastrophe. Rerun the arithmetic LineVest published nine days ago and the price traders